Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

800 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry.
Mathur S, Christou G, Delage R, Elemary M, Finn N, Geddes M, Houston DS, Keating MM, Khalaf D, Leber B, Leitch H, Lother SA, Mozessohn L, Nevill T, Parmentier A, Paulson K, Rimmer E, Sabloff M, Shamy A, St-Hilaire E, Storring J, Yee K, Zhang L, Zhu N, Hay AE, Zarychanski R, Buckstein R, Houston BL. Mathur S, et al. Among authors: yee k. Ann Hematol. 2024 Dec;103(12):5241-5248. doi: 10.1007/s00277-024-06096-x. Epub 2024 Nov 22. Ann Hematol. 2024. PMID: 39572410
Buprenorphine/naloxone initiation and referral as a quality improvement intervention for patients who live with opioid use disorder: quantitative evaluation of provincial spread to 107 rural and urban Alberta emergency departments.
Stone KD, Scott K, Holroyd BR, Lang E, Yee K, Taghizadeh N, Deol J, Dong K, Fanaeian J, Ghosh M, Low K, Ross M, Tanguay R, Faris P, Day N, McLane P. Stone KD, et al. Among authors: yee k. CJEM. 2023 Jul;25(7):598-607. doi: 10.1007/s43678-023-00520-3. Epub 2023 May 28. CJEM. 2023. PMID: 37245202 Free PMC article.
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial.
Cortes JE, Roboz GJ, Baer MR, Jonas BA, Schiller GJ, Yee K, Ferrell PB, Yang J, Wang ES, Blum WG, Mims A, Tian H, Sheppard A, de Botton S, Montesinos P, Curti A, Watts JM; Olutasidenib Combination Therapy Study Group. Cortes JE, et al. Among authors: yee k. J Hematol Oncol. 2025 Jan 16;18(1):7. doi: 10.1186/s13045-024-01657-z. J Hematol Oncol. 2025. PMID: 39819505 Free PMC article. Clinical Trial.
A generic and dynamic measure of health-related quality of life across a variety of health and disease conditions: insights from healthy individuals and patients with a variety of diagnoses.
Bujang MA, Lai WH, Tiong XT, Kim ARJ, Husin M, Jee YYH, Ahmad NFD, Tan CHH, Yee KS, Hon YK, Chew CH, Yap EPP, Johari F, Fong AYY. Bujang MA, et al. Among authors: yee ks. BMC Res Notes. 2025 Jan 3;18(1):2. doi: 10.1186/s13104-024-07037-7. BMC Res Notes. 2025. PMID: 39754261 Free PMC article.
800 results